Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd engages in the research and development, production, and sales of chemical raw materials and pharmaceutical preparations in China. The company provides drugs for the treatment of anemia, mental disorders, anti-psychotic disorders, cardiovascular and cerebrovascular diseases, and tumors. It provides drugs in the form of tablets and … Read more
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd (301130) - Total Liabilities
Latest total liabilities as of September 2025: CN¥105.74 Million CNY
Based on the latest financial reports, Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd (301130) has total liabilities worth CN¥105.74 Million CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd - Total Liabilities Trend (2011–2024)
This chart illustrates how Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd Competitors by Total Liabilities
The table below lists competitors of Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Seah Steel Corp
KO:003030
|
Korea | ₩3.11 Trillion |
|
AIRO Group Holdings, Inc. Common Stock
NASDAQ:AIRO
|
USA | $35.03 Million |
|
Ocean Plastics Co Ltd
TW:1321
|
Taiwan | NT$5.62 Billion |
|
Deceuninck N.V.
LSE:0MEL
|
UK | €373.19 Million |
|
Echoiq Ltd
AU:EIQ
|
Australia | AU$718.61K |
|
Shanghai Shibei Hi-Tech Co Ltd B
SHG:900902
|
China | $12.41 Billion |
|
Ricardo plc
F:RIR
|
Germany | €273.90 Million |
Liability Composition Analysis (2011–2024)
This chart breaks down Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 6.30 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.12 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.10 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd (2011–2024)
The table below shows the annual total liabilities of Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥121.41 Million | +43.97% |
| 2023-12-31 | CN¥84.33 Million | +17.60% |
| 2022-12-31 | CN¥71.71 Million | +1.77% |
| 2021-12-31 | CN¥70.47 Million | -10.39% |
| 2020-12-31 | CN¥78.64 Million | -6.54% |
| 2019-12-31 | CN¥84.14 Million | -7.99% |
| 2018-12-31 | CN¥91.45 Million | +1.75% |
| 2017-12-31 | CN¥89.88 Million | +63.20% |
| 2014-12-31 | CN¥55.07 Million | -38.85% |
| 2013-12-31 | CN¥90.06 Million | +16.48% |
| 2012-12-31 | CN¥77.32 Million | -16.01% |
| 2011-12-31 | CN¥92.06 Million | -- |